Total Payments
$9,538
2024 Payments
$1,192
Companies
41
Transactions
478
Medicare Patients
4,656
Medicare Billing
$408,486
Payment Breakdown by Category
Food & Beverage$8,163 (85.6%)
Other$823.77 (8.6%)
Gifts$452.67 (4.7%)
Education$99.00 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,163 | 468 | 85.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $559.69 | 1 | 5.9% |
| Gift | $452.67 | 4 | 4.7% |
| Long term medical supply or device loan | $178.44 | 3 | 1.9% |
| Education | $99.00 | 1 | 1.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $85.64 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,002 | 138 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,205 | 69 | $0 (2024) |
| FUJIFILM Medical Systems USA, Inc. | $1,098 | 6 | $0 (2020) |
| Janssen Biotech, Inc. | $852.01 | 56 | $0 (2024) |
| PFIZER INC. | $621.75 | 36 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $422.54 | 4 | $0 (2021) |
| QOL Medical, LLC | $339.40 | 21 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $338.79 | 10 | $0 (2018) |
| Boston Scientific Corporation | $259.76 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $239.03 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,192 | 68 | ABBVIE INC. ($404.91) |
| 2023 | $1,090 | 69 | ABBVIE INC. ($277.08) |
| 2022 | $1,155 | 60 | ABBVIE INC. ($515.49) |
| 2021 | $1,172 | 60 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($325.83) |
| 2020 | $915.95 | 30 | FUJIFILM Medical Systems USA, Inc. ($452.67) |
| 2019 | $982.87 | 53 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($269.89) |
| 2018 | $1,289 | 69 | Synergy Pharmaceuticals Inc ($204.82) |
| 2017 | $1,742 | 69 | FUJIFILM Medical Systems USA, Inc. ($559.69) |
All Payment Transactions
478 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Rare Disease | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.58 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: LIVER DISEASE | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.09 | General |
| 11/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.69 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/15/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: VIROLOGY | ||||||
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: LIVER DISEASE | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Boston Scientific Corporation | Axios (Device) | Food and Beverage | In-kind items and services | $101.92 | General |
| Category: Axios_ENDO | ||||||
| 09/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,172 | 1,333 | $667,385 | $106,647 |
| 2022 | 17 | 1,112 | 1,256 | $632,305 | $101,744 |
| 2021 | 16 | 1,065 | 1,205 | $577,755 | $98,186 |
| 2020 | 19 | 1,307 | 1,520 | $645,480 | $101,909 |
Total Patients
4,656
Total Services
5,314
Medicare Billing
$408,486
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 225 | $37,125 | $19,758 | 53.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 69 | 70 | $113,050 | $13,629 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 178 | $19,580 | $10,867 | 55.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $23,275 | $10,753 | 46.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 118 | 124 | $126,480 | $10,009 | 7.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 57 | 57 | $65,550 | $9,357 | 14.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 56 | 56 | $64,400 | $7,002 | 10.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 38 | 38 | $43,700 | $6,665 | 15.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $51,285 | $4,797 | 9.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 114 | 171 | $26,100 | $4,226 | 16.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $35,670 | $3,476 | 9.7% |
| 43450 | Dilation of esophagus | Facility | 2023 | 64 | 67 | $43,675 | $1,999 | 4.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $4,620 | $1,977 | 42.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 62 | 76 | $7,700 | $1,508 | 19.6% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 60 | 68 | $5,175 | $623.63 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 208 | $34,320 | $17,864 | 52.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 67 | 67 | $108,205 | $12,622 | 11.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 108 | 108 | $26,460 | $11,727 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 198 | $21,780 | $11,582 | 53.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 66 | 67 | $77,050 | $8,662 | 11.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 104 | 108 | $110,160 | $7,970 | 7.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 45 | 45 | $51,750 | $7,917 | 15.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 32 | 32 | $36,800 | $5,475 | 14.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 29 | 29 | $38,135 | $3,853 | 10.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 104 | 136 | $21,150 | $3,601 | 17.0% |
About John Hodges, M. D
John Hodges, M. D is a Gastroenterology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013945930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Hodges, M. D has received a total of $9,538 in payments from pharmaceutical and medical device companies, with $1,192 received in 2024. These payments were reported across 478 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,163).
As a Medicare-enrolled provider, Hodges has provided services to 4,656 Medicare beneficiaries, totaling 5,314 services with total Medicare billing of $408,486. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Augusta, GA
- Active Since 06/29/2006
- Last Updated 09/06/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1013945930
Products in Payments
- STELARA (Biological) $1,213
- ESD - Core Endoscopy (Device) $1,098
- XIFAXAN (Drug) $792.01
- XELJANZ (Drug) $581.40
- RINVOQ (Biological) $424.50
- LINZESS (Drug) $371.98
- TRULANCE (Drug) $345.93
- Trulance (Drug) $338.79
- HUMIRA (Biological) $267.67
- ZEPOSIA (Drug) $262.15
- SKYRIZI (Biological) $256.30
- Humira (Biological) $250.41
- MAVYRET (Drug) $210.52
- Sucraid (Drug) $196.48
- FUJIFILM (Device) $178.44
- Movantik (Drug) $168.13
- DIFICID (Drug) $145.76
- SUCRAID (Drug) $142.92
- ENTYVIO (Biological) $129.98
- Cimzia (Drug) $128.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Augusta
Sunil Lal, M.d, M.D
Gastroenterology — Payments: $50,281
Gastroenterology $50,281
Dr. Lawrence Lahatte, M.d, M.D
Gastroenterology — Payments: $9,006
Gastroenterology $9,006
Dr. Matthew Cranford, M. D, M. D
Gastroenterology — Payments: $8,349
Gastroenterology $8,349
Dr. William Curtis, M.d, M.D
Gastroenterology — Payments: $8,094
Gastroenterology $8,094
Dr. Daniel Castresana, M.d, M.D
Gastroenterology — Payments: $6,924
Gastroenterology $6,924
Dr. Steven Ellison, M.d, M.D
Gastroenterology — Payments: $6,678
Gastroenterology $6,678